ClotProtect secures £1.2m from Lifted Ventures angels and Innovate UK
The funding combines angel investment with Innovate UK support to advance medical technology development.
Share allotment filed at Companies House
Leeds-based medical technology company developing solutions to improve patient safety and reduce risks associated with blood clots.
ClotProtect has secured £1.2m through a combination of Innovate UK funding and angel investment from Lifted Ventures. The Leeds-based medical technology firm will use the proceeds to advance its technology, navigate clinical and regulatory pathways, and expand commercial operations.
The funding follows the company's participation in the Elevate Her Accelerator programme, backed by Leeds City Council. Lifted Ventures and its angel network contributed £600k alongside public funding to support the business as it scales its patient safety solutions.
Investor perspective
"Helen is an exceptional founder tackling a critical healthcare challenge. Supporting her through Elevate Her and continuing to mentor her as she built momentum towards a £1.2 million round is exactly what Lifted Ventures is about. Securing angel investment alongside public funding is essential."
Jordan Dargue
Board Director, NorthInvest
Use of funds
- 01Continue product development
- 02Fund research and development
- 03Fund the next phase of growth
Investors
Categories
About the company
ClotProtect
Developing technologies to improve patient safety and mitigate blood clot risks.